According to correspondence between the U.S. Environmental Protection Agency (EPA) and DuPont, the manufacture of perfluorooctanoic acid (PFOA) recently came to a halt – two years ahead of the 2015 deadline agreed to in the 2010/2015 PFOA Stewardship Program. It appears that DuPont, the sole manufacturer of PFOA in the U.S., stopped production, use, and import of the dangerous chemical in June of this year. The news that this compound will not be manufactured in the U.S. anymore is a very positive development.
PFOA is a chemical compound in the perfluorocarbon (PFC) family. It was used in hundreds of industrial and commercial products, including non-stick cookware, waterproof clothing, fire retardants, and insulation for electrical wiring and computer chip processing. PFCs are dangerous because they have been linked to pregnancy-induced hypertension and preeclampsia, testicular cancer, kidney cancer, ulcerative colitis, thyroid disease and high cholesterol. These chemicals persist in the environment for long periods of time and have been found in blood samples of the general population in the U.S. and throughout the world.
Our team of lawyers in the Toxic Torts section at Beasley Allen has litigated cases in Minnesota, New Jersey and Alabama in efforts to curtail PFC contamination. The fact that PFOA will no longer be manufactured, used, or imported in the U.S. is an offshoot of their hard and dedicated work. If you need additional information on this subject, contact Rhon Jones or Brantley Fry, lawyers in our Toxic Torts Section, at 800-898-2034 or by email at Rhon.Jones@beasleyallen.com or Brantley.Fry@beasleyallen.com.
Sources: Bloomberg BNA Daily Environment Report
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.